
Sophia Genetics
VerifiedHelps clinicians and physicians predict genetic diseases better
Launch date
Employees
Ownership
Market cap
$169m
Net debt
-
Firm valuation
$1.1b (Public information from Jul 2021)
Share price
$2.64 SOPH
Saint-Sulpice Canton of Vaud (HQ)
Deals in current and previous year:
RELATED LANDSCAPES AND LISTS
Financials
EditEUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E |
---|---|---|---|---|---|---|---|
Revenues | 5m | 4m | 4m | - | - | - | - |
% growth | - | (20 %) | - | - | - | - | - |
Source: Company fillings or news article
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - Not yet verified | |
N/A | Seed | ||
* | N/A | Spinout | |
N/A | CHF100k | Debt | |
N/A | Seed | ||
N/A | CHF3.8m | Series A | |
$13.8m | Series B | ||
$15m | Series C | ||
* | $30m | Series D | |
€67m | Series E | ||
$110m | Series F | ||
N/A | $234m Valuation: $1.1b | IPO | |
Total Funding | $246m |
Recent News about Sophia Genetics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Sophia Genetics
Edit
exited

ACQUISITION by Sophia Genetics Jun 2018